Achalasia and diffuse esophageal spasm: spectrum of findings and complementary roles of barium studies and manometry.
Primary achalasia is an idiopathic condition in which there is loss of the ganglion cells in the myenteric plexuses of the esophagus. (7,8) This motility disorder leads to the absence of peristalsis in the body of the esophagus and incomplete relaxation of the LES.
Primary achalasia usually develops in young or middle-aged adults <50 years of age. (9) Achalasia is an insidious disease that progresses slowly over a period of many years. As a result, affected individuals typically present with long-standing dysphagia, which has a mean duration of 4 to 5 years at the time of diagnosis. (9,10) Most patients are able to maintain their nutritional intake with little, if any, weight loss. (9) Less frequently, these individuals may present with chest pain, regurgitation of undigested food, or recurrent aspiration pneumonias. (3-5) Because symptoms are caused by incomplete relaxation of the LES, these patients usually have a marked clinical response to procedures for improving LES function, including endoscopic balloon dilation of the LES, botulinum toxin injections at the gastroesophageal junction, and, if necessary, laparoscopic or open surgical myotomy. (1-5)
Primary achalasia is classically characterized on manometry by absent peristalsis in the body of the esophagus and incomplete relaxation of the LES, often accompanied by elevated LES resting pressures (ie, a hypertensive LES). (1-3) However, some patients with achalasia have nonperistaltic contractions in the esophagus, and others have normal LES function on manometry. "Vigorous" achalasia, a common variant of achalasia that is characterized by simultaneous, ineffective, relatively high-amplitude contractions, has been found to account for as many as 30% of all cases of achalasia. (11,12) The degree of relaxation of the LES on manometry is not a reliable criterion for diagnosing this condition, as some patients with typical clinical and radiographic findings of achalasia are found to have complete relaxation of the LES on manometry. (13-15) Therefore, it is important to be aware of the spectrum of manometric findings in these patients.
Primary achalasia is characterized on barium studies by a dilated, flaccid esophagus with absent primary peristalsis in the esophageal body and impaired opening of the LES, causing a smooth, tapered, beaklike narrowing of the distal esophagus at or directly adjacent to the gastroesophageal junction (Figure 1). (3,16,17) In patients with vigorous achalasia, barium studies may also reveal repetitive nonperistaltic contractions in the esophagus, which manifested as multiple indentations on the barium column that vary in size and shape at fluoroscopy. Depending on the degree of LES dysfunction, a standing column of barium typically develops in the esophagus, with emptying of barium into the stomach only after the column reaches a critical height. In patients with more long-standing dysphagia, the esophagus becomes progressively more dilated (sometimes with considerable retained fluid and debris), eventually assuming a tortuous or so-called "sigmoid" configuration (Figures 2 and 3). (16,17)
[FIGURE 1 OMITTED]
[FIGURE 2 OMITTED]
Barium studies versus manometry
In various studies, it has been shown that 20% to 30% of patients with typical features of achalasia on barium studies have complete relaxation of the LES and, in some cases, normal LES resting pressures on manometry (Figure 4). (13-15) Despite the variable manometric findings, dysphagia in these individuals usually resolves after endoscopic or surgical treatment for achalasia. Thus, some patients with achalasia on barium studies may have no evidence of LES dysfunction on manometry. These observations raise questions about the role of manometry in patients with dysphagia and suspected achalasia. If barium studies reveal typical findings of achalasia, such patients can probably be treated without need for manometry, avoiding the cost, inconvenience, and discomfort of this procedure. Nevertheless, manometry may still be required for patients with clinically suspected achalasia who have equivocal or negative radiographic examinations. Therefore, in patients with typical radiographic findings of achalasia, the barium study can be used to guide treatment without need for manometry. If the radiographic findings are equivocal, however, manometry should be performed for a more certain diagnosis. (15)
Secondary achalasia (also known as pseudoachalasia) is caused by a malignant tumor at the gastroesophageal junction, (18-23) or, less commonly, by benign conditions such as Chagas' disease. (24) Nearly 75% of patients with secondary achalasia are found to have an underlying carcinoma of the cardia, (20) but secondary achalasia may also be caused by carcinoma of the esophagus or by other malignant tumors that metastasize to the gastroesophageal junction, including carcinoma of the lung, breast, pancreas, uterus, ovary, colon, and prostate. (18,21-23)
Because secondary achalasia is usually caused by malignant tumor, affected individuals tend to be older patients (>60 years of age), with recent onset of dysphagia (<6 months in duration) and substantial weight loss. (25) These clinical parameters contrast strikingly with those of primary achalasia, which tends to occur in younger people with long-standing dysphagia and little or no weight loss. (9,10) Therefore, the clinical presentation is extremely helpful in differentiating the primary and secondary forms of the disease in patients with radiographic or manometric findings of achalasia. Nevertheless, overlap in these clinical parameters has been reported. (26,27) In various studies, as many as 28% to 38% of patients with primary achalasia have been found to be >60 years of age, (26,27) so patient age is not an infallible criterion for differentiating primary from secondary achalasia.
[FIGURE 3 OMITTED]
The manometric findings in secondary achalasia may be indistinguishable from those in primary achalasia. At endoscopy, however, it is more difficult to advance the endoscope into the stomach in patients with secondary achalasia than it is in those with primary achalasia because of tumor circumferentially encasing the gastroesophageal junction. (20,27,28) This observation, therefore, should increase the endoscopist's suspicion of secondary achalasia.
[FIGURE 4 OMITTED]
In patients with secondary achalasia, barium studies usually reveal absent primary peristalsis in the body of the esophagus with tapered, beaklike narrowing of the distal esophagus near the gastroesophageal junction, mimicking the appearance of primary achalasia (Figure 5). However, other radiographic findings (such as eccentricity, nodularity, angulation, straightening, or shouldering of the narrowed distal segment) should raise concern about the possibility of secondary achalasia (Figure 6). (18,21,22,29) Although these classic findings of secondary achalasia are present in only a small percentage of cases, investigators recently found that the narrowed distal esophageal segment is >3.5 cm in 80% of patients with secondary achalasia but rarely exceeds 3.5 cm in patients with primary achalasia (Figures 6 and 7). (10) Thus, the length of the narrowed segment appears to be the single best criterion for differentiating primary achalasia from secondary achalasia on barium studies. Also, the esophagus tends to be considerably more dilated in primary achalasia than in secondary achalasia, (10) presumably because of the more gradual course of the disease that allows the esophagus to progressively dilate over a period of years.
When achalasia is detected on barium studies, it is extremely important to evaluate the gastric cardia and fundus to rule out malignant tumor at the gastroesophageal junction as the cause of these findings. An advanced tumor at the cardia may be manifested on barium studies by a polypoid or ulcerated mass in this region or by an infiltrating or scirrhous lesion encasing the gastric fundus (Figure 5B). (18,20,29) In other patients, barium studies may reveal thickened, lobulated folds and irregular areas of nodularity or ulceration that distort or obliterate the normal cardiac rosette, (29) so optimal double-contrast technique is required to detect these lesions. Nevertheless, the cardia and fundus cannot be adequately evaluated on radiographic studies in many patients with secondary achalasia because of delayed emptying of barium from the esophagus (so, paradoxically, the stomach empties faster than it fills with barium). 10 Radiologists, therefore, should be aware of the limitations of barium studies in evaluating the cardia and fundus in patients with suspected achalasia.
[FIGURE 5 OMITTED]
[FIGURE 6 OMITTED]
Computed tomography (CT) may reveal asymmetric thickening of the distal esophageal wall, a soft tissue mass at the cardia, or mediastinal adenopathy in patients with secondary achalasia. (30) In contrast, CT typically reveals little or no esophageal wall thickening and no evidence of a mass at the cardia in patients with primary achalasia. (30-32) Therefore, CT may be extremely helpful in differentiating primary achalasia from secondary achalasia when the clinical or radiographic findings are equivocal. CT may also be helpful in identifying the site of the primary tumor or other evidence of metastatic disease in patients with secondary achalasia caused by remote neoplasms.
[FIGURE 7 OMITTED]
Diffuse esophageal spasm
Some investigators believe that DES is a distinct esophageal motility disorder characterized by intermittently abnormal esophageal peristalsis with normal function of the LES. However, others believe that it may progress over time to the classic form of achalasia with absent peristalsis in the body of the esophagus and impaired relaxation of the LES. (33,34) It has been postulated that degeneration of the vagal nerve in the parasympathetic system is the common underlying pathway for the development of both DES and achalasia. (34)
[FIGURE 8 OMITTED]
Patients with DES classically present with chest pain, dysphagia, or both. (4,5) When patients with DES have chest pain because of high-amplitude esophageal contractions, drugs such as calcium-channel blockers, long-acting nitrates, and anticholinergics have been shown to decrease the amplitude of these contractions, sometimes ameliorating the patient's symptoms. (4) However, recent work has shown that dysphagia is a more common finding in patients with DES, at least partly because of the high frequency of LES dysfunction in these individuals (see discussion of manometric findings and radiographic findings in this article). (35) Such patients may experience marked relief of dysphagia from endoscopic balloon dilatation of the LES or injection of the botulinum toxin at the gastroesophageal junction. (35-37)
Diffuse esophageal spasm is characterized on manometry by intermittently abnormal primary peristalsis associated with a pattern of repetitive, simultaneous, ineffective contractions of varying amplitudes. (4-6) However, manometric studies have also shown that DES is frequently associated with LES dysfunction and that more than one third of these patients have incomplete relaxation of the LES during swallowing. (38) Another related condition, vigorous achalasia (see discussion of achalasia), may closely resemble DES with associated LES dysfunction on manometry, except that patients with vigorous achalasia have no episodes of normal peristalsis, whereas patients with DES have some episodes of normal peristalsis. (11,12) In the past, some investigators have even questioned the existence of vigorous achalasia as a separate disease entity, instead hypothesizing that achalasia and DES represent opposite ends of a spectrum of related esophageal motility disorders, with vigorous achalasia occurring as a transitional phase between DES and achalasia. (34)
The classic description of DES on barium studies includes the presence of repetitive, simultaneous, lumen-obliterating nonperistaltic contractions that compartmentalize the esophagus, producing a distinctive "corkscrew," "rosary bead," or "shish kebab" appearance (Figure 8). (16,17,39) In a recent study, however, lumen-obliterating nonperistaltic contractions were detected on barium studies in <15% of all patients with DES. (35) Instead, most patients had nonperistaltic contractions of varying magnitude that did not obliterate the esophageal lumen (Figure 9). Thus, radiologists should recognize that the severity of nonperistaltic contractions can vary in patients with DES and that the absence of a "corkscrew esophagus" on barium studies in no way excludes this diagnosis.
[FIGURE 9 OMITTED]
[FIGURE 10 OMITTED]
Although DES is not traditionally thought to be associated with LES dysfunction on barium studies, (17,39) recent literature suggests that the majority of patients with DES have impaired LES opening on barium studies with the tapered, beaklike distal esophageal narrowing that is typically associated with achalasia (Figure 10). (35) In a recent study, nearly two thirds of all patients with DES were found to have impaired LES opening on barium studies. (35) Thus, it should be recognized that DES is characterized radiographically by frequent LES dysfunction with nonperistaltic contractions of varying severity, rather than a classic corkscrew appearance on barium studies.
Hiatal hernias appear to be more common in patients with DES and associated LES dysfunction than in those with achalasia (Figure 10). In one study, 89% of patients with DES and impaired opening of the LES had hiatal hernias on barium studies. (35) Although hiatal hernias are uncommon in patients with achalasia, another study found an increased frequency of hiatal hernias in patients with achalasia who were >50 years of age. (40) Thus, the higher frequency of hiatal hernias in patients with DES and LES dysfunction could be related to the older age of these individuals.
Barium studies versus manometry
Although there may be discordance between the findings on barium studies and manometry in the evaluation of DES, most patients with impaired opening of the LES on barium studies or incomplete relaxation of the LES on manometry who were treated with endoscopic balloon dilatation or botulinum toxin injections at the gastroesophageal junction have had a positive response to therapy. (35) These data suggest that barium studies and manometry have complementary roles in the evaluation of patients with DES. Radiologists and gastroenterologists should be aware of the radiographic and manometric features of LES dysfunction in patients with DES, so they can guide proper treatment of these individuals.
Barium studies and manometry have complementary roles in the evaluation of achalasia and DES. Furthermore, these motor abnormalities should be considered opposite ends of a spectrum of related esophageal motility disorders, with many patients having combined radiographic and manometric features of achalasia and DES.
(1.) Castell DO. Achalasia and diffuse esophageal spasm. Arch Intern Med. 1976;136:571-579.
(2.) Katz PO, Castell DO. Review: Esophageal motility disorders. Am J Med Sci. 1985;290:61-69.
(3.) Vaezi MF, Richter JE. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol. 1999;94:3406-3412.
(4.) Richter JE. Oesophageal motility disorders. Lancet. 2001;358:823-828.
(5.) Adler DG, Romero Y. Primary esophageal motility disorders. Mayo Clin Proc. 2001;76:195-200.
(6.) Richter JE, Castell DO. Diffuse esophageal spasm: A reappraisal. Ann Intern Med. 1984;100:242-245.
(7.) Cassella RR, Brown AL Jr, Sayre GP, Ellis FH Jr. Achalasia of the esophagus: Pathologic and etiologic considerations. Ann Surg. 1964;160:474-487.
(8.) Csendes A, Smok G, Braghetto I, et al. Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus. Dig Dis Sci. 1985;30:941-945.
(9.) Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am. 1989;18:223-255.
(10.) Woodfield CA, Levine MS, Rubesin SE, et al. Diagnosis of primary versus secondary achalasia: Reassessment of clinical and radiographic criteria. AJR Am J Roentgenol. 2000;175:727-731.
(11.) Goldenberg SP, Burrell M, Fette GG, et al. Classic and vigorous achalasia: A comparison of manometric, radiographic and clinical findings. Gastroenterology. 1991;101:743-748.
(12.) Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: Original description requires minor change. J Clin Gastroenterol. 2001;33:375-377.
(13.) Katz PO, Richter JE, Cowan R, Castell DO. Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology. 1986;90:978-983.
(14.) Ott DJ, Richer JE, Chen YM, et al. Radiographic and manometric correlation in achalasia with apparent relaxation of the lower esophageal sphincter. Gastrointest Radiol. 1989;14:1-5.
(15.) Amaravadi R, Levine MS, Rubesin SE, et al. Achalasia with complete relaxation of lower esophageal sphincter: Radiographic-manometric correlation. Radiology. 2005;235:886-891.
(16.) Laufer I. Motor disorders of the esophagus. In: Levine MS, ed. Radiology of the Esophagus. Philadelphia, PA: WB Saunders Co; 1989:229-246.
(17.) Ott DJ. Motility disorders of the esophagus. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology, 2nd ed. Philadelphia, PA: WB Saunders Co; 2000:316-328.
(18.) Lawson TL, Dodds WJ. Infiltrating carcinoma simulating achalasia. Gastrointest Radiol. 1976;1: 245-248.
(19.) McCallum RW. Esophageal achalasia secondary to gastric carcinoma: Report of a case and a review of the literature. Am J Gastroenterol. 1979;71:24-29.
(20.) Kahrilas PJ, Kishk SM, Helm JF, et al. Comparison of pseudoachalasia and achalasia. Am J Med. 1987; 82;439-446.
(21.) Feczko PJ, Halpert RD. Achalasia secondary to nongastrointestinal malignancies. Gastrointest Radiol. 1985;10:273-276.
(22.) Joffe N. Right-angled narrowing of the distal oesophagus secondary to carcinoma of the tail of the pancreas. Clin Radiol. 1979;30:33-37.
(23.) Eaves R, Lambert J, Rees J, King RW. Achalasia secondary to carcinoma of prostate. Dig Dis Sci. 1983; 28:278-284.
(24.) Ferreira-Santos R. Aperistalsis of the esophagus and colon etiologically related to Chagas' disease. Am J Dig Dis. 1961;6:700-726.
(25.) Tucker HJ, Snape WJ, Cohen S. Achalasia secondary to carcinoma: Manometric and clinical features. Ann Intern Med. 1978;89:315-318.
(26.) Sandler RS, Bozymski EM, Orlando RC. Failure of clinical criteria to distinguish between primary achalasia and achalasia secondary to tumor. Dig Dis Sci. 1982;27:209-213.
(27.) Tracey JP, Traube M. Difficulties in the diagnosis of pseudoachalasia. Am J Gastroenterol. 1994;89: 2014-2018.
(28.) Rozman RW Jr, Achkar E. Features distinguishing secondary achalasia from primary achalasia. Am J Gastroenterol. 1990;85:1327-1330.
(29.) Levine MS. Other malignant tumors of the esophagus. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology, 2nd ed. Philadelphia, PA: WB Saunders Co; 2000:435-451.
(30.) Carter M, Deckmann RC, Smith RC, et al. Differentiation of achalasia from pseudoachalasia by computed tomography. Am J Gastroenterol. 1997;92: 624-628.
(31.) Tishler JM, Shin MS, Stanley RJ, Koehler RE. CT of the thorax in patients with achalasia. Dig Dis Sci. 1983;28:692-697.
(32.) Rabushka LS, Fishman EK, Kuhlman JE. CT evaluation of achalasia. J Comput Assist Tomogr. 1991;15:434-439.
(33.) Kramer P, Harris LD, Donaldson RM Jr. Transition from diffuse spasm to cardiospasm. Gut. 1967;8: 115-119.
(34.) Millan MS, Bourdages R, Beck IT, Da Costa LR. Transition from diffuse esophageal spasm to achalasia. J Clin Gastroenterol. 1979;1:107-117.
(35.) Prabhakar A, Levine MS, Rubesin S, et al. Relationship between diffuse esophageal spasm and lower esophageal sphincter dysfunction on barium studies and manometry in 14 patients. AJR Am J Roentgenol. 2004;183:409-413.
(36.) Ebert EC, Ouyang A, Wright SH, et al. Pneumatic dilatation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci. 1983;28:481-485.
(37.) Miller LS, Pullela SV, Parkman HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol. 2002;97: 1640-1646.
(38.) DiMarino AJ Jr. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology. 1974;66:1-6.
(39.) Chen YM, Ott DJ, Hewson EG, et al. Diffuse esophageal spasm: Radiographic and manometric correlation. Radiology. 1989;170:807-810.
(40.) Goldenberg SP, Vos C, Burrell M, Traube M. Achalasia and hiatal hernia. Dig Dis Sci. 1992;37:528-531.
E-Z-HD 250% weight/volume (w/v) high-density barium suspension (E-Z-EM Co., Westbury, NY)
* Entrobar 50% w/v barium sulfate suspension (Lafayette Pharmaceuticals/Mallinckrodt, St. Louis, MO).
* Baros Effervescent Granules (Lafayette Pharmaceuticals/Mallinckrodt)
* Diagnost 76 Plus digital fluoroscopy unit (Philips Medical Systems, Eindhoven, the Netherlands)
Marc S. Levine, MD
Dr. Levine is the Chief of Gastrointestinal Radiology, Department of Radiology, Hospital of the University of Pennsylvania, and a Professor of Radiology and an Advisory Dean, University of Pennsylvania School of Medicine, Philadelphia, PA. He is also on the editorial board of this journal.
|Printer friendly Cite/link Email Feedback|
|Author:||Levine, Marc S.|
|Article Type:||Clinical report|
|Date:||May 1, 2006|
|Previous Article:||Advanced MR techniques in brain tumor imaging.|
|Next Article:||MR imaging of upper extremity sarcomas.|